Preview

Medical alphabet

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Optimization of fine-needle aspiration biopsy of the thyroid nodes in complex diagnostic situations

https://doi.org/10.33667/2078-5631-2024-17-22-26

Abstract

Purpose of the study. To identify the most informative combinations of small non-coding RNA molecules (miRNA) associated with malignant tumors of the thyroid gland (TG) in patients with nodular formations with an uncertain conclusion based on fine needle aspiration biopsy (FNA) and the absence of gene mutations.

Materials and methods. The study included 83 patients with thyroid nodules according to the results of ultrasound examination with an indefinite cytological conclusion based on FAB materials (category III–V according to the Bethesda classification) and the absence of V600E mutations in the BRAF gene, NRAS, HRAS, KRAS genes in the molecular genetic study of the aspirate. Expression activity of miRNA was determined by realtime PCR in aspirate. Using cluster analysis, homogeneous groups of miRNAs associated with malignant thyroid lesions in patients were identified.

Results. In the cells of thyroid nodules obtained during FNA, malignant lesions are associated with an increase in the expression activity of miRNA‑146b,–221,–222,–885–5p and a decrease in the expression of miRNA‑455–3p and miRNA‑574–3p. Reciprocal changes in expression activity in pairs miRNA‑146b/miRNA‑574–3p, miRNA‑221/miRNA‑455–3p, miRNA‑222/miRNA‑574–3p, miRNA‑885–5p/miRNA‑574–3p are more informative when differential diagnosis of benign and malignant thyroid formations than assessing the expression of individual miRNAs.

Conclusion. With an uncertain cytological conclusion based on the FAB data of thyroid nodules (categories III–V according to the Bethesda classification) and negative results of a molecular genetic study regarding gene mutations, it is recommended to direct further diagnostic search in determining the expression in the aspirate of miRNA‑146b,–221,–222,–885–5p,–455–3p,–574–3p.

About the Authors

A. B. Alnikin
Rostov State Medical University
Russian Federation

Alnikin Alexandr B. - PhD Med, chief physician of the clinic

Rostov-on-Don



O. I. Kit
Federal State Budgetary Institution «National Medical Research Center of Oncology of the Ministry of Health of Russia»
Russian Federation

Kit Oleg I. - DM Sci (habil.), Academician of the Russian Academy of Sciences, general director

Rostov-on-Don



M. A. Engibaryan
Federal State Budgetary Institution «National Medical Research Center of Oncology of the Ministry of Health of Russia»
Russian Federation

Engibaryan Marina A. - DM Sci (habil.), Professor, head of Dept of Head and Neck Tumours

Rostov-on-Don



A. A. Demidova
Rostov State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Demidova Alexandra A. - DM Sci (habil.), associate professor, head of Dept of Medical Physics, Mathematics and Information Technology

Rostov-on-Don



A. Yu. Maksimov
Federal State Budgetary Institution «National Medical Research Center of Oncology of the Ministry of Health of Russia»
Russian Federation

Maksimov Alexey Yu. - DM Sci (habil.), professor, deputy general director

Rostov-on-Don

 



N. N. Timoshkina
Federal State Budgetary Institution «National Medical Research Center of Oncology of the Ministry of Health of Russia»
Russian Federation

Timoshkina Natalia N. - PhD Med, Head. laboratory of Molecular oncology

Rostov-on-Don



A. A. Rogachev
Rostov State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Rogachev Artem A. - surgeon at Surgical Dept

Rostov-on-Don



References

1. Belcevich D.G., Mudunov A.M., Vanushko V.E., Rumyancev P.O., Mel’nichenko G.A., Kuznecov N. S. et al. Differentiated thyroid cancer. Clinical guidelines. Sovremennaya onkologiya (Modern Oncology). 2020; 22 (4): 30–44. (In Russ.). Doi: 10.26442/18151434.2020.4.200507

2. Ohori N.P., Schoedel K.E. Variability in the atypia of undetermined significance/ follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Acta Cytol. 2011; 55 (6): 492–498. DOI: https://doi.org/10.1159/000334218.

3. Mihajlova A.A., Shestakov A.V., Chubakova K.A., Kolokolova E.V., Eliseev V. Yu., Kostyaeva M. Ya. et al. Modern concepts of molecular pathogenesis of thyroid cancer. Uspekhi molekulyarnoj onkologii (Advances in molecular oncology). 2021; 8 (2): 8–22. DOI: 10.17650/2313–805X2021–8–2–8–22)

4. Kachko V. A., Semkina G. V., Platonova N. M., Vanushko V. E., Abrosimov A. Yu. Diagnosis of neoplasms of the thyroid gland. Endocrine surgery (Endokrinnaya hirurgiya). 2018; 12 (3): 109–127. (In Russ.). DOI: https://doi.org/10.14341/serg9977

5. Semina E.V., Rysenkova K.D., Troyanovskij K.E., Shmakova A.A., Rubina K.A. MicroRNA in oncology: from mechanisms of gene expression regulation to reprogramming of the metastatic niche. Biohimiya (Biochemistry). 2021; 86 (5): 672–688. (In Russ.). DOI: 10.31857/S0320972521050055

6. Serdyukova O. S., Titov S.E., Malahina E. S., Rymar O.D. MicroRNAs are promising molecular markers for detecting cancer in thyroid nodules. Klinicheskaya i eksperimental’naya tireoidologiya (Clinical and experimental thyroidology). 2018; 14 (3): 140–148. (In Russ.). https://doi.org/10.14341/ket9774

7. Pishkari S., Paryan M., Hashemi M., Baldini E, Mohammadi-Yeganeh S. The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies. J Endocrinol Invest. 2018; 41 (3): 269–283. DOI: 10.1007/s40618–017–0735–6

8. Titov S. E., Ivanov M.K., Civlikova E. V., Ganzha M. S., Malahina E. S., Maleko A.V. et al. Analysis of the relative expression of the HMGA2 gene and oncogenic microRNA-221 in cytological preparations obtained by fine-needle aspiration biopsy of thyroid nodules. Uspekhi molekulyarnoj onkologii (Advances in molecular oncology). 2017; 4: 24–31. (In Russ.). DOI: 10.17650/2313–805X-2017–4–4–24–31

9. Knyazeva M. S., Zabegina L.M., Sidina E.I., Karickij A.A., Cyrlina E.V., Artem’eva A.S. et al. Peculiarities of microRNA expression profile in anaplastic thyroid cancer tissue. Issues of oncology (Voprosy onkologii). 2021; 67 (1): 70–76. (In Russ.). DOI: 10.37469/0507–3758–2021–67–1–70–76

10. Braga E. A., Pronina I. V., Filippova E. A., Burdennyy A. M., Lukina S. S., Loginov V.I., Kushlinsky D.N. et al. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics). 2023; 68 (1): 56–64. (in Russ.). https://doi.org/10.51620/0869–2084–2023–68–1–56–64


Review

For citations:


Alnikin A.B., Kit O.I., Engibaryan M.A., Demidova A.A., Maksimov A.Yu., Timoshkina N.N., Rogachev A.A. Optimization of fine-needle aspiration biopsy of the thyroid nodes in complex diagnostic situations. Medical alphabet. 2024;(17):22-26. (In Russ.) https://doi.org/10.33667/2078-5631-2024-17-22-26

Views: 250


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)